KRON
KRONOS BIO INC
No data for this timeframe.
Vol
Inst. Holders7 funds
Inst. Value$2.6M
Inst. Activity0 buys / 4 sells
Recent Activity
Inst.
VANGUARD GROUP INC — EXIT
0 shares ($0.00)
Inst.
MORGAN STANLEY — EXIT
0 shares ($0.00)
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $1.6M | EXIT |
| RENAISSANCE TECHNOLOGIES LLC | $909.4K | EXIT |
| TWO SIGMA INVESTMENTS, LP | $46.1K | EXIT |
| CITADEL ADVISORS LLC | $42.2K | TRIM |
| MORGAN STANLEY | $31.2K | EXIT |
7 institutional holders with $2.6M total value (3,175,033 shares) as of 2025-Q1. Top holders: VANGUARD, RENAISSANCE, TWO. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 1,922,809 | $1.6M | 60.6% | EXIT -100.0% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 1,102,326 | $909.4K | 34.7% | EXIT -100.0% |
| 3 | TWO SIGMA INVESTMENTS, LP | 55,935 | $46.1K | 1.8% | EXIT -100.0% |
| 4 | CITADEL ADVISORS LLC | 51,200 | $42.2K | 1.6% | TRIM -74.0% |
| 5 | MORGAN STANLEY | 37,795 | $31.2K | 1.2% | EXIT -100.0% |
| 6 | FMR LLC | 4,600 | $3.8K | 0.1% | — |
| 7 | BANK OF AMERICA CORP /DE/ | 368 | $304.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | EXIT | 1,922,809 | 0 | -100.0% | $0.00 | 2025-Q2 |
| MORGAN STANLEY | EXIT | 37,795 | 0 | -100.0% | $0.00 | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 1,102,326 | 0 | -100.0% | $0.00 | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 55,935 | 0 | -100.0% | $0.00 | 2025-Q2 |
| CITADEL ADVISORS LLC | TRIM | 196,811 | 51,200 | -74.0% | $42.2K | 2025-Q1 |
| CITADEL ADVISORS LLC | DOUBLED | 96,601 | 196,811 | +103.7% | $187.0K | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.